Rat Models of Hormone Receptor-Positive Breast Cancer

DeSantis CE et al. Breast cancer statistics, 2019 CA: A Cancer Journal for Clinicians, 2019. 69(6): pp. 438–451.

Sung H, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49.

Article  Google Scholar 

Perou CM, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747–52.

Article  CAS  PubMed  Google Scholar 

Nolan E, Lindeman GJ, Visvader JE. Deciphering breast cancer: from biology to the clinic. Cell. 2023;186(8):1708–28.

Article  CAS  PubMed  Google Scholar 

Goldhirsch A, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast Cancer 2013. Ann Oncol. 2013;24(9):2206–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Polyak K. Heterogeneity in breast cancer. J Clin Investig. 2011;121(10):3786–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sørlie T, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98(19):10869–74.

Article  PubMed  PubMed Central  Google Scholar 

Schnitt SJ. Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Mod Pathol. 2010;23:S60–4.

Article  PubMed  Google Scholar 

Goldhirsch A, et al. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast Cancer 2011. Ann Oncol. 2011;22(8):1736–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma CX, Bose R, Ellis MJ. Prognostic and Predictive Biomarkers of Endocrine Responsiveness for Estrogen Receptor Positive Breast Cancer, in Novel Biomarkers in the Continuum of Breast Cancer, V. Stearns, Editor. 2016, Springer International Publishing: Cham. pp. 125–154.

Yoon K-H, et al. Effect of Estrogen Receptor Expression Level and hormonal therapy on prognosis of early breast Cancer. Cancer Res Treat. 2022;54(4):1081–90.

Article  CAS  PubMed  Google Scholar 

Hanker AB, Sudhan DR, Arteaga CL. Overcoming Endocr Resist Breast Cancer Cancer Cell. 2020;37(4):496–513.

CAS  Google Scholar 

D’Souza A, Spicer D, Lu J. Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer. J Hematol Oncol. 2018;11(1):80.

Article  PubMed  PubMed Central  Google Scholar 

Neve RM, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006;10(6):515–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sachs N, et al. A living biobank of breast Cancer Organoids captures Disease Heterogeneity. Cell. 2018;172(1–2):373–e38610.

Article  CAS  PubMed  Google Scholar 

Dekkers JF, et al. Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids. Nat Protoc. 2021;16(4):1936–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Turrell FK, et al. Age-associated microenvironmental changes highlight the role of PDGF-C in ER(+) breast cancer metastatic relapse. Nat Cancer. 2023;4(4):468–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Perez-Lanzon M et al. New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma. J Immunother Cancer, 2023. 11(6).

Drost J, Clevers H. Organoids in cancer research. Nat Rev Cancer. 2018;18(7):407–18.

Article  CAS  PubMed  Google Scholar 

Corrò C, Novellasdemunt L, Li VSW. A brief history of organoids. Am J Physiol Cell Physiol. 2020;319(1):C151–65.

Article  PubMed  PubMed Central  Google Scholar 

Day CP, Merlino G, Van Dyke T. Preclinical mouse cancer models: a maze of opportunities and challenges. Cell. 2015;163(1):39–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gillet JP, Varma S, Gottesman MM. The clinical relevance of cancer cell lines. J Natl Cancer Inst. 2013;105(7):452–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou Y, et al. Experimental mouse models for translational human cancer research. Front Immunol. 2023;14:1095388.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Z, Wei L, Ce-Shi C. Breast cancer animal models and applications. Zoological Res. 2020;41(5):477.

Article  Google Scholar 

Cameron DA, et al. Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates tumour regression. Breast Cancer Res Treat. 1997;45(2):99–107.

Article  CAS  PubMed  Google Scholar 

Fleming JM, et al. Local regulation of human breast xenograft models. J Cell Physiol. 2010;224(3):795–806.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hartman J, et al. Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res. 2006;66(23):11207–13.

Article  CAS  PubMed  Google Scholar 

Kim MH, et al. Identification for antitumor effects of tramadol in a xenograft mouse model using orthotopic breast cancer cells. Sci Rep. 2021;11(1):22113.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sflomos G, et al. A preclinical model for ERα-Positive breast Cancer points to the epithelial microenvironment as determinant of Luminal phenotype and hormone response. Cancer Cell. 2016;29(3):407–22.

Article  CAS  PubMed  Google Scholar 

Jiang G, et al. Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer. BMC Genomics. 2016;17(Suppl 7):525.

Article  PubMed  PubMed Central  Google Scholar 

Kao J, et al. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS ONE. 2009;4(7):e6146.

Article  PubMed  PubMed Central  Google Scholar 

Kenny PA, et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol. 2007;1(1):84–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wen Y, et al. Cell subpopulation deconvolution reveals breast cancer heterogeneity based on DNA methylation signature. Brief Bioinform. 2017;18(3):426–40.

CAS  PubMed  Google Scholar 

Zhu Y, et al. Estrogen receptor alpha positive breast tumors and breast cancer cell lines share similarities in their transcriptome data structures. Int J Oncol. 2006;29(6):1581–9.

CAS  PubMed 

Comments (0)

No login
gif